Lower rate of PONV with ropivacaine wound infiltration vs IV analgesia after thoracolumbar surgery .
Continuous wound infusion of ropivacaine for the control of pain after thoracolumbar spinal surgery: a randomized clinical trial
Eur Spine J. 2017 Mar;26(3):825-83171 patients scheduled for instrumented thoracolumbar surgery were randomized to postoperative analgesia with either continuous wound infiltration with ropivacaine or continuous intravenous infusion of flurbiprofen axetil and pentazocine. Patients were assessed for pain scores, the requirement of rescue analgesia, and adverse events over the first 48 hours postoperatively. There was no difference in pain scores between groups over the first 48 hours. A significantly lower incidence of postoperative nausea and vomiting was documented in the continuous wound infiltration group compared to the intravenous analgesia group. All other secondary outcomes did not significantly differ between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
